Literature DB >> 26349421

Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment.

Meera Murgai1, Amber Giles1, Rosandra Kaplan1.   

Abstract

The primary tumor niche and the related but distinct premetastatic/metastatic niche comprise a number of essential players, including immune cells, stromal cells, and extracellular matrix. The cross-talk between these components is key to tumor progression. Many of these cell types and signaling pathways in the tumor microenvironment also are found in physiological and stem cell niches, such as the bone marrow, colonic crypt, and skin bulge. Here they play tightly regulated roles in wound healing and tissue homeostasis. Understanding the similarities and differences between these distinct niches may better inform our ability to therapeutically target the tumor microenvironment. In this review we discuss a number of tumor and metastatic niche components as they relate to stem cell niches and highlight potential therapeutic strategies in pediatric cancers.

Entities:  

Mesh:

Year:  2015        PMID: 26349421      PMCID: PMC5562358          DOI: 10.1615/critrevoncog.2015013668

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  103 in total

1.  Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells.

Authors:  Scott A Bergfeld; Laurence Blavier; Yves A DeClerck
Journal:  Mol Cancer Ther       Date:  2014-02-06       Impact factor: 6.261

Review 2.  Angiogenesis in neuroblastoma.

Authors:  Domenico Ribatti; Danilo Marimpietri; Fabio Pastorino; Chiara Brignole; Beatrice Nico; Angelo Vacca; Mirco Ponzoni
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

Review 3.  Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.

Authors:  H F Dvorak; J A Nagy; A M Dvorak
Journal:  Cancer Cells       Date:  1991-03

4.  Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors.

Authors:  Jukka Vakkila; Ronald Jaffe; Marilyn Michelow; Michael T Lotze
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

5.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

6.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction.

Authors:  Juliana Hamzah; Manfred Jugold; Fabian Kiessling; Paul Rigby; Mitali Manzur; Hugo H Marti; Tamer Rabie; Sylvia Kaden; Hermann-Josef Gröne; Günter J Hämmerling; Bernd Arnold; Ruth Ganss
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

7.  S100 chemokines mediate bookmarking of premetastatic niches.

Authors:  Shahin Rafii; David Lyden
Journal:  Nat Cell Biol       Date:  2006-12       Impact factor: 28.824

8.  Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.

Authors:  Younghun Jung; Jin Koo Kim; Yusuke Shiozawa; Jingcheng Wang; Anjali Mishra; Jeena Joseph; Janice E Berry; Samantha McGee; Eunsohl Lee; Hongli Sun; Jianhua Wang; Taocong Jin; Honglai Zhang; Jinlu Dai; Paul H Krebsbach; Evan T Keller; Kenneth J Pienta; Russell S Taichman
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 9.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.

Authors:  Catherine M Kolf; Elizabeth Cho; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

Review 10.  Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.

Authors:  Jagdeep K Singh; Bruno M Simões; Sacha J Howell; Gillian Farnie; Robert B Clarke
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

View more
  7 in total

Review 1.  Skeletal complications in cancer patients with bone metastases.

Authors:  Shunsuke Tsuzuki; Sun Hee Park; Matthew R Eber; Christopher M Peters; Yusuke Shiozawa
Journal:  Int J Urol       Date:  2016-08-03       Impact factor: 3.369

Review 2.  Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?

Authors:  Petr Busek; Jonathan S Duke-Cohan; Aleksi Sedo
Journal:  Cancers (Basel)       Date:  2022-04-21       Impact factor: 6.575

Review 3.  Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.

Authors:  Sugandha Saxena; Rakesh K Singh
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

4.  KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis.

Authors:  Meera Murgai; Wei Ju; Matthew Eason; Jessica Kline; Daniel W Beury; Sabina Kaczanowska; Markku M Miettinen; Michael Kruhlak; Haiyan Lei; Jack F Shern; Olga A Cherepanova; Gary K Owens; Rosandra N Kaplan
Journal:  Nat Med       Date:  2017-09-18       Impact factor: 53.440

5.  Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity.

Authors:  Jiliang Feng; Dawei Zhao; Fudong Lv; Zhongyu Yuan
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

6.  Oleic Acid Uptake Reveals the Rescued Enterocyte Phenotype of Colon Cancer Caco-2 by HT29-MTX Cells in Co-Culture Mode.

Authors:  Emmanuelle Berger; Merian Nassra; Claude Atgié; Pascale Plaisancié; Alain Géloën
Journal:  Int J Mol Sci       Date:  2017-07-20       Impact factor: 5.923

7.  NLGP Attenuates Murine Melanoma and Carcinoma Metastasis by Modulating Cytotoxic CD8+ T Cells.

Authors:  Avishek Bhuniya; Ipsita Guha; Nilanjan Ganguly; Akata Saha; Shayani Dasgupta; Partha Nandi; Arnab Das; Sarbari Ghosh; Tithi Ghosh; Enamul Haque; Saptak Banerjee; Anamika Bose; Rathindranath Baral
Journal:  Front Oncol       Date:  2020-03-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.